Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dexter, TM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Clemons, M; Watson, A; Howell, A; Chang, J; Heyworth, C; Lord, B; Testa, N; Dexter, TM; Margison, G
      Macrophage inflammatory protein 1 alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells

      CLINICAL CANCER RESEARCH
    2. Pierce, A; Spooncer, E; Wooley, S; Dive, C; Francis, JM; Miyan, J; Owen-Lynch, PJ; Dexter, TM; Whetton, AD
      Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation

      ONCOGENE
    3. Dexter, TM
      The role of the Wellcome Trust in support of biomedical research

      JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON
    4. Francis, JM; Heyworth, CM; Spooncer, E; Pierce, A; Dexter, TM; Whetton, AD
      Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. McIvor, ZJ; Heyworth, CM; Johnson, BA; Pearson, S; Fiegler, H; Hampson, L; Dexter, TM; Cross, MA
      A transient assay for regulatory gene function in haemopoietic progenitor cells

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Jelinek, J; Rafferty, JA; Cmejla, R; Hildinger, M; Chinnasamy, D; Lashford, LS; Ostertag, W; Margison, GP; Dexter, TM; Fairbairn, LJ; Baum, C
      A novel dual function retrovirus expressing multidrug resistance 1 and O-6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents

      GENE THERAPY
    7. Durig, J; Testa, NG; Lord, BI; Kasper, C; Chang, J; Telford, N; Dexter, TM; Heyworth, CM
      Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1 alpha

      LEUKEMIA
    8. Chinnasamy, N; Rafferty, JA; Lashford, LS; Chinnasamy, D; Margison, GP; Thatcher, N; Dexter, TM; Fairbairn, LJ
      Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy

      LEUKEMIA
    9. Johnson, BA; John, VA; Henschler, R; Hampson, IN; Heyworth, CM; Babichuk, CK; Bleackley, RC; Dexter, TM; Cross, MA
      Upstream elements bestow T-cell and haemopoietic progenitor-specific activity on the granzyme B promoter

      GENE
    10. Scheller, M; Foerster, J; Heyworth, CM; Waring, JF; Lohler, J; Gilmore, GL; Shadduck, RK; Dexter, TM; Horak, I
      Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein

      BLOOD
    11. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; LASHFORD LS; THATCHER N; MARGISON GP; DEXTER TM; RAFFERTY JA
      CHEMOPROTECTIVE GENE-TRANSFER - I - TRANSDUCTION OF HUMAN HEMATOPOIETIC PROGENITORS WITH O-6-BENZYLGUANINE-RESISTANT O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ATTENUATES THE TOXIC EFFECTS OF O-6-ALKYLATING AGENTS IN-VITRO

      Gene therapy
    12. CHINNASAMY N; RAFFERTY JA; HICKSON I; LASHFORD LS; LONGHURST SJ; THATCHER N; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

      Gene therapy
    13. MARSHALL E; HOWELL AH; POWLES R; HUNTER MG; EDWARDS M; WOOD LM; CZAPLEWSKI L; PUTTICK R; WARRINGTON S; BOYCE M; TESTA N; DEXTER TM; LORD BI; MILLAR A
      CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010

      European journal of cancer
    14. PIERCE A; OWENLYNCH PJ; SPOONCER E; DEXTER TM; WHETTON AD
      P210 BCR-ABL EXPRESSION IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELLLINE MODELS THE DEVELOPMENT OF CHRONIC MYELOID-LEUKEMIA

      Oncogene
    15. WARK G; HEYWORTH CM; SPOONCER E; CZAPLEWSKI L; FRANCIS JM; DEXTER TM; WHETTON AD
      ABL PROTEIN-KINASE ABROGATES THE RESPONSE OF MULTIPOTENT HEMATOPOIETIC-CELLS TO THE GROWTH INHIBITOR MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA

      Oncogene
    16. DURIG J; TESTA NG; LORD BI; KASPER C; CHANG J; TELFORD N; DEXTER TM; HEYWORTH CM
      CHARACTERIZATION OF THE DIFFERENTIAL RESPONSE OF NORMAL AND CML HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA

      Annals of oncology
    17. PEARSON MA; OFARRELL AM; DEXTER TM; WHETTON AD; OWENLYNCH PJ; HEYWORTH CM
      INVESTIGATION OF THE MOLECULAR MECHANISMS UNDERLYING GROWTH-FACTOR SYNERGY - THE ROLE OF ERK-2 ACTIVATION IN SYNERGY

      Growth factors
    18. KASPER C; SCHWARZER A; DEWYNTER EA; CHANG J; DEXTER TM; RYDER D; TESTA NG
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF) INCREASES THE NUMBERS OF MEGAKARYOCYTE PROGENITOR CELLS TO NORMAL VALUES IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS WITH AML IN FIRST REMISSION

      Leukemia
    19. WEAVER A; CHANG J; WRIGLEY E; DEWYNTER E; WOLL PJ; LIND M; JENKINS B; GILL C; WILKINSON PM; PETTENGELL R; RADFORD JA; COLLINS CD; DEXTER TM; TESTA NG; CROWTHER D
      RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER

      Journal of clinical oncology
    20. BUREL S; HEYWORTH CM; GEORGE E; DEXTER TM
      THE FACTOR-DEPENDENT CELL-LINE PATERSON MIX AS MODEL SYSTEM FOR ROUTINE ASSESSMENT OF MYELOTOXICITY IN-VITRO

      Experimental hematology
    21. ROBERTSON J; WYNN R; CROSS M; HATTON C; LASHFORD LS; WILL AM; DEXTER TM; TESTA N
      ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANT

      Bone marrow transplantation
    22. WYNN RF; CROSS MA; HATTON C; WILL AM; LASHFORD LS; DEXTER TM; TESTA NG
      ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS

      Lancet
    23. PIERCE A; WHETTON AD; OWENLYNCH PJ; TAVERNIER J; SPOONCER E; DEXTER TM; HEYWORTH CM
      ECTOPIC INTERLEUKIN-5 RECEPTOR EXPRESSION PROMOTES PROLIFERATION WITHOUT DEVELOPMENT IN A MULTIPOTENT HEMATOPOIETIC-CELL LINE

      Journal of Cell Science
    24. PIERCE A; HEYWORTH CM; NICHOLLS SE; SPOONCER E; DEXTER TM; LORD JM; OWENLYNCH PJ; WARK G; WHETTON AD
      AN ACTIVATED PROTEIN-KINASE-C-ALPHA GIVES A DIFFERENTIATION SIGNAL FOR HEMATOPOIETIC PROGENITOR CELLS AND MIMICS MACROPHAGE-COLONY-STIMULATING FACTOR-STIMULATED SIGNALING EVENTS

      The Journal of cell biology
    25. MORRIS EC; KELLY SL; HAMPSON IN; HAMPSON L; DEXTER TM; CARRELL RW; COUGHLIN PB
      NUCLEAR-LOCALIZATION OF HEMATOPOIETIC SERPIN 2A - A POTENTIAL REGULATOR OF APOPTOSIS

      British Journal of Haematology
    26. DURIG J; CHANG J; KASPER C; TELFORD N; DEWYNTER EA; TESTA NG; CROSS MA; CHOPRA R; HEYWORTH CM; LORD BI; DEXTER TM
      DIFFERENTIAL RESPONSIVENESS OF CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA)

      British Journal of Haematology
    27. CLEMONS MJ; MARSHALL E; DURIG J; WATANABE K; HOWELL A; MILES D; EARL H; KIERNAN J; GRIFFITHS A; TOWLSON K; DETAKATS P; TESTA NG; DOUGAL M; HUNTER MG; WOOD LM; CZAPLEWSKI LG; MILLAR A; DEXTER TM; LORD BI
      RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY

      Blood
    28. ENVER T; HEYWORTH CM; DEXTER TM
      DO STEM-CELLS PLAY DICE

      Blood
    29. STEWART K; BROWN OA; MORELLI AE; FAIRBAIRN LJ; LASHFORD LS; COOPER A; HATTON CE; DEXTER TM; CASTRO MG; LOWENSTEIN PR
      UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO

      Gene therapy
    30. WEAVER A; WOLL PJ; LIND M; GILL C; JENKINS B; DEXTER TM; TESTA NG; CROWTHER D
      STEM-CELL FACTOR (R-METHUSCF) IN COMBINATION WITH FILGRASTIM (R-METHUG-CSF) ENHANCES PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION FOLLOWING CHEMOTHERAPY - A RANDOMIZED STUDY

      European journal of cancer
    31. BUCKINGHAM ME; DEXTER TM
      FROM THE REGULATION OF GROWTH, DIFFERENTIATION, AND DEATH IN-VITRO TOTHE ONSET AND MAINTENANCE OF DIFFERENTIATION IN-VIVO

      Current opinion in genetics & development
    32. RAFFERTY JA; CHINNASAMY N; HICKSON I; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      GENE-THERAPY FOR CHEMOPROTECTION OF BONE-MARROW FROM THE TOXIC AND CARCINOGENIC EFFECTS OF THE O-6-ALKYLATING AGENTS

      Cancer gene therapy
    33. CHINNASAMY N; HICKSON I; DEXTER TM; MARGISON GP; FAIRBAIRN LJ; RAFFERTY JA
      GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

      Cancer gene therapy
    34. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; DEXTER TM; MARGISON GP; RAFFERTY JA
      TOWARDS GENE-THERAPY FOR STEM-CELL PROTECTION USING MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

      Cancer gene therapy
    35. DURIG J; DEWYNTER EA; KASPER C; CHANG J; DEXTER TM; CROSS M; HEYWORTH CM; TESTA NG
      DIFFERENTIAL MIP-1-ALPHA-RESPONSIVENESS IN CML AND NORMAL HEMATOPOIETIC PROGENITOR CELLS

      Experimental hematology
    36. COUTINHO LH; CHANG J; BRERETON ML; MORGENSTERN GR; SCARFFE JH; HARRISON CJ; YIN JAL; DARBYSHIRE PJ; BURDACH S; DEXTER TM; TESTA NG
      AUTOGRAFTING IN PHILADELPHIA (PH)-LEUKEMIA USING CULTURED MARROW - ANUPDATE OF A PILOT-STUDY( CHRONIC MYELOID)

      Bone marrow transplantation
    37. REIPERT BM; ALLAN D; REIPERT S; DEXTER TM
      APOPTOSIS IN HEMATOPOIETIC PROGENITOR CELLS EXPOSED TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS

      Life sciences
    38. SCHOFIELD KP; RUSHTON G; HUMPHRIES MJ; DEXTER TM; GALLAGHER JT
      INFLUENCE OF INTERLEUKIN-3 AND OTHER GROWTH-FACTORS ON ALPHA(4)BETA(1) INTEGRIN-MEDIATED ADHESION AND MIGRATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS

      Blood
    39. OGORMAN P; COLLINS JK; OSULLIVAN GC; ODONOGHUE M; SHANAHAN F; DEXTER TM
      A TUMOR-DERIVED MOLECULE INDUCES APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA AND MEDIATES SELECTIVE HEMATOPOIETIC PROGENITOR SUPPRESSION

      Blood
    40. CHINNASAMY N; RAFFERTY JA; HICKSON I; ASHBY J; TINWELL H; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      O-6-BENZYLGUANINE POTENTIATES THE IN-VIVO TOXICITY AND CLASTOGENICITYOF TEMOZOLOMIDE AND BCNU IN MOUSE BONE-MARROW

      Blood
    41. HAMPSON IN; HAMPSON L; PINKOSKI M; CROSS M; HEYWORTH CM; BLEACKLEY RC; ATKINSON E; DEXTER TM
      IDENTIFICATION OF A SERPIN SPECIFICALLY EXPRESSED IN MULTIPOTENT AND BIPOTENT HEMATOPOIETIC PROGENITOR CELLS AND IN ACTIVATED T-CELLS

      Blood
    42. HICKSON I; FAIRBAIRN LJ; CHINNASAMY N; DEXTER TM; MARGISON GP; RAFFERTY JA
      PROTECTION OF MAMMALIAN-CELLS AGAINST CHLOROETHYLATING AGENT TOXICITYBY AN O-6-BENZYLGUANINE-RESISTANT MUTANT OF HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

      Gene therapy
    43. BRETTI S; GILLEECE MH; KAMTHAN A; FITZSIMMONS L; HICKS F; ROWLANDS M; BISHOP P; PICARDO AM; DEXTER TM; SCARFFE JH
      AN OPEN PHASE-I STUDY TO ASSESS THE BIOLOGICAL EFFECTS OF A CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 FOLLOWED BY GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR

      European journal of cancer
    44. BAUMANN I; SWINDELL R; VANHOEFF MEHM; DEXTER TM; DEWYNTER E; LANGE C; LUFT T; HOWELL A; TESTA NG
      MOBILIZATION KINETICS OF PRIMITIVE HEMATOPOIETIC-CELLS FOLLOWING G-CSF WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED BREAST-CANCER

      Annals of oncology
    45. REIPERT BM; ALLAN D; DEXTER TM
      EXPOSURE TO EXTREMELY-LOW-FREQUENCY MAGNETIC-FIELDS HAS NO EFFECT ON GROWTH-RATE OR CLONOGENIC POTENTIAL OF MULTIPOTENTIAL HEMATOPOIETIC PROGENITOR CELLS

      Growth factors
    46. HAMPSON IN; HAMPSON L; DEXTER TM
      DIRECTIONAL RANDOM OLIGONUCLEOTIDE PRIMED (DROP) GLOBAL AMPLIFICATIONOF CDNA - ITS APPLICATION TO SUBTRACTIVE CDNA CLONING

      Nucleic acids research
    47. WEAVER A; RYDER D; DEXTER TM; CROWTHER D; TESTA NG
      INCREASING NUMBERS OF LONG-TERM CULTURE - INITIATING CELLS (LTC-IC) ARE MOBILIZED INTO THE PERIPHERAL-BLOOD WITH INCREASING DOSES OF STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) AND CHEMOTHERAPY

      Experimental hematology
    48. HEYWORTH CM; DEXTER TM; CROSS MA; ALLEN TD; TESTA NG
      MEGAKARYOCYTIC DEVELOPMENT OF A MULTIPOTENT STEM-CELL LINE, FDCP-MIX

      Experimental hematology
    49. WARK G; PIERCE A; LORD JM; HEYWORTH CM; SPOONCER E; DEXTER TM; WHETTON AD
      RETROVIRAL INFECTION OF GRANULOCYTE-MACROPHAGE PROGENITOR CELLS WITH CONSTITUTIVELY ACTIVE PROTEIN-KINASE C-ALPHA PROMOTES MACROPHAGE DEVELOPMENT

      Experimental hematology
    50. KASPER C; SCHWARZER A; DEWYNTER FA; CHANG J; DEXTER TM; TESTA NG
      STIMULATORY EFFECTS OF RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR IN LONG-TERM BONE-MARROW CULTURES OF PATIENTS OF ACUTEMYELOID-LEUKEMIA

      Experimental hematology
    51. RAFFERTY JA; HICKSON I; CHINNASAMY N; LASHFORD LS; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      CHEMOPROTECTION OF NORMAL-TISSUES BY TRANSFER OF DRUG-RESISTANCE GENES

      Cancer metastasis reviews
    52. FAIRBAIRN LJ; LASHFORD LS; SPOONCER E; MCDERMOTT RH; LEBENS G; ARRAND JE; ARRAND JR; BELLANTUONO I; HOLT R; HATTON CE; COOPER A; BESLEY GTN; WRAITH JE; ANSON DS; HOPWOOD JJ; DEXTER TM
      LONG-TERM IN-VITRO CORRECTION OF ALPHA-L-IDURONIDASE DEFICIENCY (HURLER-SYNDROME) IN HUMAN BONE-MARROW

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. MARGISON GP; RAFFERTY JA; ELDER RH; KELLY J; WATSON AJ; WILLINGTON MA; LEE SM; HICKSON I; FAIRBAIRN LJ; DEXTER TM; JELINEK J; STOCKING C; BAUM C; OSTERTAG W; EGHYAZI S; HANSSON J; RINGBORG U; DONNELLY D; MCMURRY TBH; MCCORMICK J; MCELHINNEY RS
      MODULATING NITROSOUREA RESPONSE IN TUMORS AND NORMAL TISSUE - APPLICATION TO FOTEMUSTINE

      Medicamentos de actualidad
    54. GILLEECE MH; HEYWORTH CM; TESTA NG; DEXTER TM
      EFFECTS OF INTERLEUKINS ON THE PROLIFERATION AND SURVIVAL OF CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS

      Journal of Clinical Pathology
    55. COUTINHO LH; BRERETON ML; SANTOS AMW; RYDER WDJ; CHANG J; HARRISON CJ; YIN JAL; DEXTER TM; TESTA NG
      EVALUATION OF CYTOGENETIC CONVERSION TO PH(-) HEMATOPOIESIS IN LONG-TERM BONE-MARROW CULTURE FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA ON CONVENTIONAL HYDROXYUREA THERAPY, ON PULSE HIGH-DOSE HYDROXYUREA AND ON INTERFERON-ALPHA

      British Journal of Haematology
    56. OGORMAN P; COTTER P; COLLINS JK; OSULLIVAN G; ODONOGHUE M; SHANAHAN F; DEWYNTER E; DEXTER TM
      A TUMOR-DERIVED MOLECULE MEDIATES HEMATOPOIETIC STEM-CELL SUPPRESSION

      British Journal of Haematology
    57. WEAVER A; WRIGLEY E; WATSON A; CHANG J; COLLINS CD; JENKINS B; GILL C; PETTENGELL R; DEXTER TM; TESTA NG; CROWTHER D
      A STUDY OF OVARIAN-CANCER PATIENTS TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM AND CYCLOPHOSPHAMIDE

      British Journal of Cancer
    58. WEAVER A; RYDER D; CROWTHER D; DEXTER TM; TESTA NG
      INCREASED NUMBERS OF LONG-TERM CULTURE-INITIATING CELLS IN THE APHERESIS PRODUCT OF PATIENTS RANDOMIZED TO RECEIVE INCREASING DOSES OF STEM-CELL FACTOR ADMINISTERED IN COMBINATION WITH CHEMOTHERAPY AND A STANDARD-DOSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR

      Blood
    59. JELINEK J; FAIRBAIRN LJ; DEXTER TM; RAFFERTY JA; STOCKING C; OSTERTAG W; MARGISON GP
      LONG-TERM PROTECTION OF HEMATOPOIESIS AGAINST THE CYTOTOXIC EFFECTS OF MULTIPLE DOSES OF NITROSOUREA BY RETROVIRUS-MEDIATED EXPRESSION OF HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE

      Blood
    60. HEYWORTH CM; PEARSON MA; DEXTER TM; WARK G; OWENLYNCH PJ; WHETTON AD
      MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MEDIATED GROWTH-INHIBITION INA HEMATOPOIETIC STEM-CELL LINE IS ASSOCIATED WITH INOSITOL 1,4,5-TRISPHOSPHATE GENERATION

      Growth factors
    61. JUST U; KAN O; FENNELLY J; DEXTER TM; SPOONCER E
      THE HOX-2.4 GENE IS NOT INVOLVED IN THE GENERATION OF IL-3 DEPENDENT MULTIPOTENT FDCP-MIX CELL-LINES

      Growth factors
    62. PETTENGELL R; WOLL PJ; THATCHER N; DEXTER TM; TESTA NG
      MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD

      Journal of clinical oncology
    63. PEARSON M; OWEN PJ; WHETTON AD; DEXTER TM; HEYWORTH CM
      INVESTIGATION OF THE MOLECULAR MECHANISMS BY WHICH SCF SYNERGISTICALLY PROMOTES THE EFFECTS OF CYTOKINES ON FDCP-MIX A4 CELLS

      Experimental hematology
    64. WARK G; WHETTON AD; SPOONCER E; HEYWORTH CM; DEXTER TM
      MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA PROTECTS A HEMATOPOIETIC MULTIPOTENT STEM-CELL LINE FROM THE CYTOTOXIC EFFECTS OF CYCLE-SPECIFIC AGENTS - MODULATION BY ACTIVATION OF V-ABL PROTEIN-TYROSINE KINASE

      Experimental hematology
    65. LANGE C; HUMPHRIES MJ; TESTA NG; DEXTER TM
      DECREASED LEUKEMIC-CELL ADHESION DOES NOT INVOLVE FIBRONECTIN DERIVEDCS-I REGION

      Experimental hematology
    66. LORD BI; DEXTER TM
      WHICH ARE THE HEMATOPOIETIC STEM-CELLS

      Experimental hematology
    67. NICHOLLS SE; HEYWORTH CM; DEXTER TM; LORD JM; JOHNSON GD; WHETTON AD
      IL-4 PROMOTES MACROPHAGE DEVELOPMENT BY RAPIDLY STIMULATING LINEAGE RESTRICTION OF BIPOTENT GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS

      The Journal of immunology
    68. HEYWORTH CM; ALAULDIN M; CROSS MA; FAIRBAIRN LJ; DEXTER TM; WHETTON AD
      ERYTHROID DEVELOPMENT OF THE FDCP-MIX A4 MULTIPOTENT CELL-LINE IS GOVERNED BY THE RELATIVE CONCENTRATIONS OF ERYTHROPOIETIN AND INTERLEUKIN-3

      British Journal of Haematology
    69. RAGHAVACHAR A; JANSSEN JWG; SCHREZENMEIER H; WAGNER B; BARTRAM CR; SCHULZ AS; HEIN C; COWLING G; MUBARIK A; TESTA NG; DEXTER TM; HOWS JM; MARSH JCW
      CLONAL HEMATOPOIESIS AS DEFINED BY POLYMORPHIC X-LINKED LOCI OCCURS INFREQUENTLY IN APLASTIC-ANEMIA

      Blood
    70. HUNTER MG; BAWDEN L; BROTHERTON D; CRAIG S; CRIBBES S; CZAPLEWSKI LG; DEXTER TM; DRUMMOND AH; GEARING AH; HEYWORTH CM; LORD BI; MCCOURT M; VARLEY PG; WOOD LM; EDWARDS RM; LEWIS PJ
      BB-10010 - AN ACTIVE VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA WITH IMPROVED PHARMACEUTICAL PROPERTIES

      Blood
    71. HU M; HEYWORTH C; DEXTER TM; ENVER T
      SIMULTANEOUS ACTIVATION OF ERYTHROID AND MYELOID TRANSCRIPTIONAL PROGRAMS IN INDIVIDUAL MULTIPOTENTIAL HEMATOPOIETIC-CELLS PRIOR TO UNILINEAGE COMMITMENT AND DIFFERENTIATION

      Blood
    72. LASKAY G; VARHELYI T; DALE RE; DEXTER TM
      ROLE OF INTERLEUKIN-3 IN THE REGULATION OF INTERCELLULAR K-CELLS( HOMEOSTASIS IN CULTURED MURINE HEMATOPOIETIC)

      Biochemical and biophysical research communications
    73. COWLING GJ; DEXTER TM
      APOPTOSIS IN THE HEMATOPOIETIC SYSTEM

      Philosophical transactions-Royal Society of London. Biological sciences
    74. DEXTER TM
      GRANULOCYTE-COLONY-STIMULATING FACTOR - FROM LABORATORY BENCH TO CLINICAL USE

      European journal of cancer
    75. CROSS MA; HEYWORTH CM; MURRELL AM; BOCKAMP EO; DEXTER TM; GREEN AR
      EXPRESSION OF LINEAGE RESTRICTED TRANSCRIPTION FACTORS PRECEDES LINEAGE-SPECIFIC DIFFERENTIATION IN A MULTIPOTENT HEMATOPOIETIC PROGENITOR-CELL LINE

      Oncogene
    76. DEXTER TM; HEYWORTH CM
      GROWTH-FACTORS AND THE MOLECULAR CONTROL OF HEMATOPOIESIS

      European journal of clinical microbiology & infectious diseases
    77. VANHOEF MEHM; BAUMANN I; LANGE C; LUFT T; DEWYNTER EA; RANSON M; MORGENSTERN GR; YVERS A; DEXTER TM; TESTA NG; HOWELL A
      DOSE-ESCALATING INDUCTION CHEMOTHERAPY SUPPORTED BY LENOGRASTIM PRECEDING HIGH-DOSE CONSOLIDATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER -SELECTION OF THE MOST ACCEPTABLE REGIMEN TO INDUCE MAXIMAL TUMOR RESPONSE AND INVESTIGATION OF THE OPTIMAL TIME TO COLLECT PERIPHERAL-BLOODPROGENITOR CELLS FOR HEMATOLOGICAL RESCUE AFTER HIGH-DOSE CONSOLIDATION CHEMOTHERAPY

      Annals of oncology
    78. STRAKA C; PETTENGELL R; PIELMEIER A; CROSS M; EMMERICH B; CROWTHER D; TESTA NG; DEXTER TM
      A RELIABLE APPROACH FOR SEQUENCING CLONE-SPECIFIC CDRIII REGIONS IN B-CELL LYMPHOMA

      Annals of oncology
    79. FAIRBAIRN LJ; COWLING GJ; DEXTER TM; RAFFERTY JA; MARGISON GP; REIPERT B
      BCL-2 DELAY OF ALKYLATING AGENT-INDUCED APOPTOTIC DEATH IN A MURINE HEMATOPOIETIC STEM-CELL LINE

      Molecular carcinogenesis
    80. SPOONCER E; FAIRBAIRN L; COWLING GJ; DEXTER TM; WHETTON AD; OWENLYNCH PJ
      BIOLOGICAL CONSEQUENCES OF P160(V-ABL) PROTEIN-TYROSINE KINASE-ACTIVITY IN A PRIMITIVE MULTIPOTENT HEMATOPOIETIC-CELL LINE

      Leukemia
    81. JUST U; SPOONCER E; LOHLER J; STOCKING C; OSTERTAG W; DEXTER TM
      MUTANTS OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE BLOCKED IN GM-CSF-INDUCED DIFFERENTIATION ARE LEUKEMOGENIC IN-VIVO

      Experimental hematology
    82. BAUMANN I; VANHOEF MEHM; SWINDELL R; LANGE C; DEWYNTER E; HOWELL A; DEXTER TM; TESTA NG
      THE PEAK NUMBERS OF COLONY-FORMING CELLS AND OF CD34-BLOOD AFTER G-CSF (LENOGRASTIM) WITH OR WITHOUT CHEMOTHERAPY MAY NOT BE CORRELATED WITH THE CAPACITY OF HARVESTED BLOOD-CELLS TO REPOPULATE BONE-MARROW( CELLS RELEASED INTO PERIPHERAL)

      Experimental hematology
    83. WHETTON AD; HEYWORTH CM; LORD JL; DEXTER TM; NICHOLLS S; OWENLYNCH PJ
      CYTOKINE-STIMULATED PROTEIN-KINASE-C-ALPHA TRANSLOCATION TO THE NUCLEUS IS ASSOCIATED WITH COMMITMENT OF BIPOTENTIAL GRANULOCYTE-MACROPHAGECOLONY-FORMING CELLS TO MACROPHAGE DEVELOPMENT

      Experimental hematology
    84. HEYWORTH CM; DEXTER TM; NICHOLLS SE; WHETTON AD
      COMBINATIONS OF COLONY-STIMULATING FACTORS PROMOTE ENHANCED PROLIFERATIVE POTENTIAL IN ENRICHED GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS

      Experimental hematology
    85. PETTENGELL R; WOLL PJ; OCONNOR DA; DEXTER TM; TESTA NG
      VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME

      Bone marrow transplantation
    86. WHETTON AD; HEYWORTH CM; NICHOLLS SE; EVANS CA; LORD JM; DEXTER TM; OWENLYNCH PJ
      CYTOKINE-MEDIATED PROTEIN-KINASE-C ACTIVATION IS A SIGNAL FOR LINEAGEDETERMINATION IN BIPOTENTIAL GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS

      The Journal of cell biology
    87. DEXTER TM; CHANG J
      NEW STRATEGIES FOR THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA

      Blood
    88. PETTENGELL R; LUFT T; HENSCHLER R; HOWS JM; DEXTER TM; RYDER D; TESTA NG
      DIRECT COMPARISON BY LIMITING DILUTION ANALYSIS OF LONG-TERM CULTURE-INITIATING CELLS IN HUMAN BONE-MARROW, UMBILICAL-CORD BLOOD, AND BLOODSTEM-CELLS

      Blood
    89. STRAKA C; CARR T; WILL A; COUTINHO L; DEXTER TM; TESTA N
      SUCCESSFUL EX-VIVO PURGING OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS AND SIMULTANEOUS SURVIVAL OF LONG-TERM CULTURE INITIATING CELLS IN A LONG-TERM BONE-MARROW CULTURE (LTBMC) SYSTEM

      Blood
    90. MOLINEUX G; MIGDALSKA A; HALEY J; EVANS GS; DEXTER TM
      TOTAL MARROW FAILURE INDUCED BY PEGYLATED STEM-CELL FACTOR ADMINISTERED BEFORE 5-FLUOROURACIL

      Blood
    91. DEXTER TM; FAIRBAIRN LJ
      THE MOLECULAR CONTROL OF HEMATOPOIESIS

      Anti-cancer drugs
    92. DEXTER TM
      APOPTOSIS AND LEUKEMIA - REVIEW LECTURE

      Leukemia
    93. GILLEECE MH; HEYWORTH CM; TESTA NG; DEXTER TM
      INTERLEUKIN-4 RECEPTOR EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Experimental hematology
    94. COUTINHO LH; BRERETON ML; SANTOS AMW; CHANG J; HARRISON CJ; LIUYIN JA; DEXTER TM; TESTA NG
      LONG-TERM BONE-MARROW CULTURE (LTBMC) STUDIES IN CHRONIC MYELOID-LEUKEMIA (CML) - FACTORS AFFECTING THE SELECTIVE LOSS OF PH+ CELLS

      Experimental hematology
    95. BRERETON ML; COUTINHO LH; CHANG J; RICHARDS JT; HARRISON CJ; LIUYIN JA; TESTA NG; DEXTER TM
      TREATMENT OF CHRONIC MYELOID-LEUKEMIA (CML) WITH PULSE HIGH-DOSE HYDROXYUREA (HU) ALLOWS GREATER RECOVERY OF PH-CELLS IN LONG-TERM BONE-MARROW CULTURE (ITBMG) FOR AUTOTRANSPLANT

      Experimental hematology
    96. VANHOEF MEHM; BAUMANN I; LANGE C; HOWELL A; DEXTER TM; TESTA NG
      ONE APHERESIS PROCEDURE TO COLLECT PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR TRANSPLANTATION

      Experimental hematology
    97. FAIRBAIRN LJ; COWLING GJ; REIPERT BM; DEXTER TM
      SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS

      Cell
    98. DEWYNTER E; ALLEN T; COUTINHO L; FLAVELL D; FLAVELL SU; DEXTER TM
      LOCALIZATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN HUMAN LONG-TERM BONE-MARROW CULTURES - BIOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERIZATION

      Journal of Cell Science
    99. BRERETON ML; CHANG J; COUTINHO LH; HARRISON C; RICHARDS JT; DEXTER TM; TESTA NG; YIN JAL
      EVALUATION OF CYTOGENETIC CONVERSION TO PH' NEGATIVE HEMATOPOIESIS INLONG-TERM BONE-MARROW CULTURE (LTBMC) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) ON PULSE HYDROXYUREA THERAPY

      British Journal of Haematology
    100. PETTENGELL R; TESTA NG; SWINDELL R; CROWTHER D; DEXTER TM
      TRANSPLANTATION POTENTIAL OF HEMATOPOIETIC-CELLS RELEASED INTO THE CIRCULATION DURING ROUTINE CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 17:00:10